Barclays’s Maze Therapeutics, Inc. Common Stock MAZE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$180K Sell
14,641
-3
-0% -$37 ﹤0.01% 3593
2025
Q1
$161K Buy
+14,644
New +$161K ﹤0.01% 3449